Pharmacology of new antimalarial drugs. A piperazine which exerts an unusual type of adrenergic blockade.
D000109:Acetylcholine / Q000494:pharmacology; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D000962:Antimalarials / Q000494:pharmacology* / Q000633:toxicity; D002344:Carotid Body / Q000187:drug effects; D004285:Dogs; D004837:Epinephrine / Q000494:pharmacology; D006321:Heart / Q000187:drug effects; D006325:Heart Atria; D007269:Injections, Intra-Arterial; D007545:Isoproterenol / Q000494:pharmacology; D008168:Lung / Q000502:physiology; D008297:Male; D051379:Mice; D009638:Norepinephrine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D011955:Receptors, Drug; D012119:Respiration / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000962:Antimalarials; D010879:Piperazines; D011955:Receptors, Drug; D013566:Sympathomimetics; D012701:Serotonin; D007545:Isoproterenol; D000109:Acetylcholine; D009638:Norepinephrine; D004837:Epinephrine